Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact

Nature Communications

Volumn 5, Issue , 2014, Pages

  Li, Lei ^a   Wei, Yuhong ^a   To, Christine ^b   Zhu, Chang Qi ^b   Tong, Jiefei ^a   Pham, Nhu An ^b   Taylor, Paul ^a   Ignatchenko, Vladimir ^b   Ignatchenko, Alex ^b   Zhang, Wen ^a,c   Wang, Dennis ^b   Yanagawa, Naoki ^b   Li, Ming ^b   Pintilie, Melania ^b,d   Liu, Geoffrey ^b,c   Muthuswamy, Lakshmi ^c,e   Shepherd, Frances A ^b,c   Tsao, Ming Sound ^b,c   Kislinger, Thomas ^b,c   Moran, Michael F ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME; DNA; RNA; TRANSCRIPTOME;

CANCER; CLUSTER ANALYSIS; DNA; GERM CELL; METABOLISM; PHENOTYPE; PROTEIN; PROTEOMICS;

ARTICLE; CANCER SURVIVAL; GENE AMPLIFICATION; GENOME; GENOMICS; NON SMALL CELL LUNG CANCER; PHENOTYPE; PROTEIN METABOLISM; ADENOCARCINOMA; CLUSTER ANALYSIS; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; PROGNOSIS; PROTEOMICS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CLUSTER ANALYSIS; DISEASE PROGRESSION; DNA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMANS; LUNG NEOPLASMS; PROGNOSIS; PROTEOME; PROTEOMICS; RNA; TRANSCRIPTOME;

EID: 84922621177     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6469     Document Type: Article

References (68)

1. Parmigiani, G., et al. Design and analysis issues in genome-wide somatic mutation studies of cancer. Genomics 93, 17-21 (2009
2. Kandoth, C., et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333-339 (2013
3. Imielinski, M., et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107-1120 (2012
4. TCGA. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519-525 (2012
5. Vogelstein, B. & Kinzler, K. W. Cancer genes and the pathways they control. Nat. Med. 10, 789-799 (2004
6. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011
7. John, T., et al. The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer. Clin. Cancer Res. 17, 134-141 (2011
8. DeRose, Y. S., et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat. Med. 17, 1514-1520 (2011
9. Campbell, P. J., et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109-1113 (2010
10. Ding, L., et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999-1005 (2010
11. Nemati, F., et al. Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors. Clin. Cancer Res. 16, 2352-2362 (2010
12. Tentler, J. J., et al. Patient-derived tumour xenografts as models for oncology drug development. Nat. Rev. Clin. Oncol. 9, 338-350 (2012
13. Michalski, A., et al. Ultra high resolution linear ion trap Orbitrap mass spectrometer (Orbitrap Elite) facilitates top down LC MS/MS and versatile peptide fragmentation modes. Mol. Cell. Proteomics 11, O111 013698 (2012
14. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008
15. Kikuchi, T., et al. In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers. Mol. Cell. Proteomics 11, 916-932 (2012
16. Chen, G., et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics 1, 304-313 (2002
17. Gygi, S. P., Rochon, Y., Franza, B. R. & Aebersold, R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19, 1720-1730 (1999
18. Franovic, A., et al. Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer. Proc. Natl Acad. Sci. USA 104, 13092-13097 (2007
19. Mosesson, Y., Mills, G. B. & Yarden, Y. Derailed endocytosis: an emerging feature of cancer. Nat. Rev. Cancer 8, 835-850 (2008
20. Kalisman, N., Adams, C. M. & Levitt, M. Subunit order of eukaryotic TRiC/CCT chaperonin by cross-linking, mass spectrometry, and combinatorial homology modeling. Proc. Natl Acad. Sci. USA 109, 2884-2889 (2012
21. Leitner, A., et al. The molecular architecture of the eukaryotic chaperonin TRiC/CCT. Structure 20, 814-825 (2012
22. Hartl, F. U., Bracher, A. & Hayer-Hartl, M. Molecular chaperones in protein folding and proteostasis. Nature 475, 324-332 (2011
23. Sternlicht, H., et al. The t-complex polypeptide 1 complex is a chaperonin for tubulin and actin in vivo. Proc. Natl Acad. Sci. USA 90, 9422-9426 (1993
24. Hansen, W. J., et al. Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity. Mol. Cell. Biol. 22, 1947-1960 (2002
25. Melki, R., Batelier, G., Soulie, S. & Williams, Jr. R. C. Cytoplasmic chaperonin containing TCP-1: structural and functional characterization. Biochemistry 36, 5817-5826 (1997
26. Won, K. A., Schumacher, R. J., Farr, G. W., Horwich, A. L. & Reed, S. I. Maturation of human cyclin E requires the function of eukaryotic chaperonin CCT. Mol. Cell. Biol. 18, 7584-7589 (1998
27. Boutros, P. C., et al. Prognostic gene signatures for non-small-cell lung cancer. Proc. Natl Acad. Sci. USA 106, 2824-2828 (2009
28. Coghlin, C., et al. Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer. J. Pathol. 210, 351-357 (2006
29. Cerami, E., et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404 (2012
30. Seo, M., Lee, W. H. & Suk, K. Identification of novel cell migration-promoting genes by a functional genetic screen. FASEB J. 24, 464-478 (2010
31. Baughman, J. M., et al. A computational screen for regulators of oxidative phosphorylation implicates SLIRP in mitochondrial RNA homeostasis. PLoS Genet. 5, e1000590 (2009
32. Aras, S., et al. Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2. Nucleic Acids Res. 41, 2255-2266 (2013
33. Wei, Y., et al. CHCHD2 is co-Amplified with EGFR in non-small cell lung carcinoma and regulates mitochondrial function and cell migration. (submitted), (2014
34. Parker, J. J., et al. Gefitinib selectively inhibits tumor cell migration in EGFRamplified human glioblastoma. Neuro Oncol. 15, 1048-1057 (2013
35. Wikman, H., et al. CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer. Genes Chromosomes Cancer 42, 193-199 (2005
36. Anderson, D. D. & Stover, P. J. SHMT1 and SHMT2 are functionally redundant in nuclear de novo thymidylate biosynthesis. PLoS ONE 4, e5839 (2009
37. Anderson, D. D., Woeller, C. F., Chiang, E. P., Shane, B. & Stover, P. J. Serine hydroxymethyltransferase anchors de novo thymidylate synthesis pathway to nuclear lamina for DNA synthesis. J. Biol. Chem. 287, 7051-7062 (2012
38. Pavon-Eternod, M., Gomes, S., Rosner, M. R. & Pan, T. Overexpression of initiator methionine tRNA leads to global reprogramming of tRNA expression and increased proliferation in human epithelial cells. RNA 19, 461-466 (2013
39. Zhang, W. C., et al. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 148, 259-272 (2012
40. Possemato, R., et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346-350 (2011
41. Vie, N., et al. Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells. Mol. Cancer 7, 14 (2008
42. Locasale, J. W., et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 43, 869-874 (2011
43. Wei, Y., et al. Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures. J. Proteome Res. 10, 161-174 (2011
44. Zhang, W., et al. Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches. Proteomics 14, 795-803 (2014
45. Nilsson, R., et al. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat. Commun. 5, 3128 (2014
46. Lee, G. Y., et al. Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes. Cancer. Res. 74, 3114-3126 (2014
47. Ye, J., et al. Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov. doi: 10.1158/2159-8290.CD-14-0250 (2014
48. Zheng, H., et al. A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses. Cell Rep. 5, 180-193 (2013
49. Vander Heiden, M. G., et al. Metabolic pathway alterations that support cell proliferation. Cold Spring Harb. Symp. Quant. Biol. 76, 325-334 (2011
50. Christofk, H. R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230-233 (2008
51. Toledo-Sherman, L., et al. New targets for an old drug: A chemical proteomics approach to unraveling the molecular mechanism of action of methotrexate. Clin. Proteomics 1, 45-67 (2004
52. Daidone, F., et al. In silico and in vitro validation of serine hydroxymethyltransferase as a chemotherapeutic target of the antifolate drug pemetrexed. Eur. J. Med. Chem. 46, 1616-1621 (2011
53. Hebbring, S. J., et al. Serine hydroxymethyltransferase 1 and 2: gene sequence variation and functional genomic characterization. J. Neurochem. 120, 881-890 (2012
54. Meyer, L. M., Miller, F. R., Rowen, M. J., Bock, G. & Rutzky, J. Treatment of acute leukemia with amethopterin (4-Amino, 10-methyl pteroyl glutamic acid). Acta Haematol. 4, 157-167 (1950
55. Abolmaali, S. S., Tamaddon, A. M. & Dinarvand, R. A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis. Cancer Chemother. Pharmacol. 71, 1115-1130 (2013
56. Scagliotti, G., et al. Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer. J. Thorac. Oncol. 6, 64-70 (2011
57. Vogelstein, B., et al. Cancer genome landscapes. Science 339, 1546-1558 (2013
58. Cox, J., et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794-1805 (2011
59. Wisniewski, J. R., et al. Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma. Mol. Syst. Biol. 8, 611 (2012
60. Wisniewski, J. R., Ostasiewicz, P. & Mann, M. High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers. J. Proteome Res. 10, 3040-3049 (2011
61. Zougman, A., et al. Retinoic acid-induced protein 3: identification and characterisation of a novel prognostic colon cancer biomarker. Eur. J. Cancer 49, 531-539 (2013
62. Vizcaino, J. A., et al. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 41, D1063-D1069 (2013
63. Diskin, S. J., et al. Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms. Nucleic Acids Res. 36, e126 (2008
64. Du, P., Kibbe, W. A. & Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547-1548 (2008
65. Pique-Regi, R., Caceres, A. & Gonzalez, J. R. R-Gada: a fast and flexible pipeline for copy number analysis in association studies. BMC bioinformatics 11, 380 (2010
66. Edgar, R., Domrachev, M. & Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic. Acids. Res. 30, 207-210 (2002
67. Beroukhim, R., et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl Acad. Sci. USA 104, 20007-20012 (2007
68. Beroukhim, R., et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899-905 (2010